Related Experiment Video
Updated: May 27, 2026
08:25
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
A close up view of pneumococcal disease
1University of Louisville Hospital, Louisville, KY, USA.
The Nurse Practitioner
|November 19, 2011
Summary
Pneumococcal disease is a persistent health risk, even with vaccines. Primary care nurse practitioners need training to effectively prevent and manage pneumococcal infections.
Area of Science:
- Infectious Diseases
- Vaccinology
- Primary Healthcare
Background:
- Pneumococcal disease continues to pose a significant public health threat.
- The availability of vaccines has not eliminated the incidence of pneumococcal infections.
- Primary care settings are crucial for managing infectious diseases.
Purpose of the Study:
- To highlight the ongoing threat of pneumococcal disease.
- To emphasize the essential role of primary care nurse practitioners in combating pneumococcal infections.
- To underscore the need for preparedness in prevention and treatment.
Main Methods:
- Literature review on pneumococcal disease epidemiology.
- Analysis of current vaccination strategies.
- Assessment of primary care nurse practitioner roles in infection management.
Main Results:
- Pneumococcal disease remains a considerable challenge in community settings.
- Vaccination alone is insufficient to eradicate the disease.
- Nurse practitioners are pivotal in both proactive prevention and reactive treatment.
Conclusions:
- Continuous vigilance against pneumococcal disease is necessary.
- Enhanced training for primary care nurse practitioners is vital for effective disease control.
- A comprehensive approach involving prevention and treatment is essential.
Related Concept Videos
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...